Clinical Trial Update: A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of Selinexor in combination with standard-of-care therapy for newly diagnosed or recurrent glioblastoma was terminated, with results posted on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Selinexor (selinexor)

Snippet

Sponsor: Karyopharm Therapeutics Inc | Conditions: Glioblastoma Multiforme | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-12-16